Haft Nicholas 4
4 · Finch Therapeutics Group, Inc. · Filed Dec 22, 2021
Insider Transaction Report
Form 4
Haft Nicholas
Director
Transactions
- Purchase
Common Stock, $0.001 par value per share
2021-12-20$10.18/sh+63,850$649,993→ 4,056,907 total(indirect: See footnote)
Footnotes (1)
- [F1]All shares are held indirectly by entities of which the reporting person is the manager. The reporting person has voluntarily reported the entire amount of such entities' interest. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any such securities.